Back to Trades
Total Value
$1.1M
Net $1.1M sold
Filing Date
Jul 17, 2026
2 transactions
Sales
$1.1M
2 transactions
Trade Summary
On Jul 14, 2026, Opaleye Management Inc., 10% Owner, sold $1.1M of Eton Pharmaceuticals, Inc. (ETON) across 2 transactions. The filing covers Common Stock, par value $0.001 per share and reflects net selling of $1.1M. Reported prices ranged from $37.54. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- Eton Pharmaceuticals, Inc.
- Ticker Symbol
- ETON
- CIK
- 0001710340
Insider Information
- Role
- 10% Owner
- Location
- BOSTON, MA
Filing Details
- Filing Date
- Jul 17, 2026
- Transaction Date
- Jul 14, 2026
- Accession Number
- 0001493152-26-033818
- Form Type
- 4
- Net Trading Amount
- -$1.1M
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Jul 14, 2026 | Common Stock, par value $0.001 per share | 15,000 | $37.54 | Sale | $563.1K |
| Jul 14, 2026 | Common Stock, par value $0.001 per share | 13,315 | $37.54 | Sale | $499.9K |
Want live alerts when Opaleye Management Inc. trades again?
Download Insider Trades to track ETON, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)Represents securities owned directly by Opaleye, L.P. (the "Fund"). As the investment manager of the Fund, Opaleye Management, Inc. may be deemed to beneficially own the securities owned directly by the Fund.
- (F2)Securities owned by a separately managed account (the "Managed Account"). As the portfolio manager of the Managed Account, Opaleye Management, Inc. may be deemed to beneficially own the securities owned directly by the Managed Account.
- (F3)The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.0152 to $37.9148 inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price.
- (F4)Opaleye Management, Inc. disclaims beneficial ownership of the shares reported herein except to the extent of its pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that Opaleye Management, Inc. is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended, or for any other purpose.